Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better

Cellular and Molecular Gastroenterology and Hepatology(2021)10.1016/j.jcmgh.2021.05.015Source: DataRank Database

Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better is a research paper published in Cellular and Molecular Gastroenterology and Hepatology (2021). On theSindex it has a DataRank of 0.165. It has been cited 2 times.

N/A

0.165DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.14)OA: goldTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.165

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (1)

Petra Hirsova ORCID

Live enrichment

PubMed:34115994 PMC:PMC8413140 OpenAlex:https://openalex.org/W3172430662

National Institutes of Health

Grant: P30DK084567

National Institute of Diabetes and Digestive and Kidney Diseases

Mayo Clinic

American Association for the Study of Liver Diseases

FWCI

0.14

Citation Percentile

0.5%

Citation Trend

2021

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.jcmgh.2021.05.015

publisherhttps://doi.org/10.1016/j.jcmgh.2021.05.015

publisherhttps://api.elsevier.com/content/article/PII:S2352345X21001041?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352345X21001041?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34115994

Fields of Study

Liver Disease Diagnosis and TreatmentHepatocellular Carcinoma Treatment and PrognosisEndoplasmic Reticulum Stress and DiseaseCarcinoma, HepatocellularHumansLiver CirrhosisLiver NeoplasmsNon-alcoholic Fatty Liver DiseaseRisk Factors

MeSH Terms

Carcinoma, HepatocellularHumansLiver CirrhosisLiver NeoplasmsRisk FactorsNon-alcoholic Fatty Liver Disease

Keywords

Nonalcoholic fatty liver diseaseHepatocellular carcinomaCirrhosisMedicineFatty liverFibrosisLiver diseaseNonalcoholic steatohepatitisSteatohepatitisBioinformaticsChronic liver diseaseDiseaseInternal medicineBiology

Sustainable Development Goals

SDG 0: Good health and well-being